Atlas Trials

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

Clinical trial NCT07692334 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07692334
Sponsor
West China Second University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug VedotinPucotenlimab
Start date
2026-07-20
Primary completion
2027-09-30
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.